Cellectar Biosciences, Inc. Common Stock (NASDAQ: CLRB) last traded at $1.39, down 2.80% on the session. The quote above updates while this page is open; the figures below are drawn from Cellectar Biosciences, Inc. Common Stock’s own filings and are restated only when a new one is published.
Cellectar Biosciences, Inc. Common Stock trades on NASDAQ under the ticker CLRB. Its market capitalisation is $13.14 million.
Valuation measures for Cellectar Biosciences, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $13.14M |
|---|---|
| Enterprise value | -$14.09M |
| Price / book | 0.44 |
| Beta | 1.42 |
Trailing-twelve-month figures tagged in Cellectar Biosciences, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$22.32M |
| EPS (TTM) | -$2.56 |
|---|
| Return on equity | -74.73% |
|---|
| Cash | $33.99M |
|---|
Range and volume for CLRB over the past 52 weeks.
| 52-week high | $5.07 |
|---|---|
| 52-week low | $1.34 |
| Volume | 532.6K |
| Average volume | 72.3K |
| Previous close | $1.43 |
Invest a chosen dollar amount in Cellectar Biosciences, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell CLRB.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.